68
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Inhibition of EGFR Signaling and Activation of Mitochondrial Apoptosis Contribute to Tanshinone IIA-Mediated Tumor Suppression in Non-Small Cell Lung Cancer Cells

, , & ORCID Icon
Pages 2757-2769 | Published online: 02 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lijie Liu, Hanjing Gao, Tao Wen, Tao Gu, Shuang Zhang & Zhiyong Yuan. (2021) Tanshinone IIA attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammation. Pharmaceutical Biology 59:1, pages 87-94.
Read now

Articles from other publishers (18)

Rutuja Damare, Kritika Engle & Gautam Kumar. (2024) Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight. Phytotherapy Research.
Crossref
Yaoquan Cao, Haibo Tang, Guohui Wang, Pengzhou Li, Zhi Song, Weizheng Li, Xulong Sun, Xiaoxiao Zhong, Qianqian Yu, Shaihong Zhu & Liyong Zhu. (2023) Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer. Cell Death Discovery 9:1.
Crossref
Fatma Fouad Hagar, Samar H. Abbas, Hesham A. M. Gomaa, Bahaa G. M. Youssif, Ahmed M. Sayed, Dalia Abdelhamid & Mohamed Abdel-Aziz. (2023) Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV600E. BMC Chemistry 17:1.
Crossref
Fei Sun, Xiaoli Yang, Wei Song, Nan Yu & Qingyi Lin. (2022) Tanshinone IIA (TSIIA) represses the progression of non-small cell lung cancer by the circ_0020123/miR-1299/HMGB3 pathway. Molecular and Cellular Biochemistry 478:9, pages 1973-1986.
Crossref
Zhicheng Wei, Jing Chen, Fang Zuo, Julie Guo, Xiaodong Sun, Deming Liu & Conghai Liu. (2023) Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: A review. Journal of Ethnopharmacology 300, pages 115748.
Crossref
Hongkui Chen, Min Zheng, Wenhui Zhang, Yuan Long, Yu Xu & Man Yuan. (2022) Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-13.
Crossref
Meng Lu, Xintian Lan, Xi Wu, Xiaoxue Fang, Yegang Zhang, Haoming Luo, Wenyi Gao & Donglu Wu. (2022) Salvia miltiorrhiza in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes. Frontiers in Pharmacology 13.
Crossref
Reem N El-Naga. (2022) Forskolin alleviates cisplatin-induced acute renal toxicity in rats. Journal of Pharmacy and Pharmacology 74:7, pages 1051-1060.
Crossref
Hailiang Qi, Zhengyi Chen, Yuhuan Qin, Xianlei Wang, Zhihua Zhang & Yazhai Li. (2022) Tanshinone IIA inhibits cell growth by suppressing SIX1‑induced aerobic glycolysis in non‑small cell lung cancer cells. Oncology Letters 23:6.
Crossref
Shuangze Han, Xiaoying Li, Yu Gan & Wei Li. (2022) Licochalcone A Promotes the Ubiquitination of c-Met to Abrogate Gefitinib Resistance. BioMed Research International 2022, pages 1-12.
Crossref
Syed Sahajada Mahafujul Alam, Faizan Uddin, Farheen Badrealam Khan, Mohammad Amjad Kamal & Mehboob Hoque. (2022) Therapeutic and pharmacological potential of Tanshinones against lung cancer: A systematic review. Phytomedicine Plus 2:1, pages 100202.
Crossref
Wenfeng Zhang, Cun Liu, Jie Li, Yiping Lu, Huayao Li, Jing Zhuang, Xin Ren, Mengmeng Wang & Changgang Sun. (2022) Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine. The American Journal of Chinese Medicine 50:01, pages 209-239.
Crossref
Teng Wang, Jun Zou, Qiong Wu, Rui Wang, Chan-Ling Yuan, Jing Shu, Bing-Bing Zhai, Xiao-Ting Huang, Ning-Zhi Liu, Feng-Yang Hua, Xi-Cheng Wang & Wen-Jie Mei. (2021) Tanshinone IIA derivatives induced S-phase arrest through stabilizing c-myc G-quadruplex DNA to regulate ROS-mediated PI3K/Akt/mTOR pathway. European Journal of Pharmacology 912, pages 174586.
Crossref
Chenhui Zhong, Zuan Lin, Liyuan Ke, Peiying Shi, Shaoguang Li, Liying Huang, Xinhua Lin & Hong Yao. (2021) Recent Research Progress (2015–2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA. Frontiers in Pharmacology 12.
Crossref
Xianglian Zhou, Yuting Pan, Yue Wang, Bojun Wang, Yu Yan, Yi Qu & Xisong Ke. (2021) Tanshinones induce tumor cell apoptosis via directly targeting FHIT. Scientific Reports 11:1.
Crossref
Qi-Xing Yan, Yun Pan, Hai-Li Huang & Hui Zhao. (2021) Therapeutic Potential of Natural Products in Lung Cancer. International Journal of Pharmacology 17:5, pages 251-261.
Crossref
Tingting Wen, Lei Song & Shucheng Hua. (2021) Perspectives and controversies regarding the use of natural products for the treatment of lung cancer. Cancer Medicine 10:7, pages 2396-2422.
Crossref
Zhiyuan Sun, Jinxiang Dong, Lijie Song, Fuqiang Li, Xue Wu, Zhidong Qiu & Donglu Wu. (2021) Network Pharmacology Validation of Therapeutic Mechanisms of Tanshinone IIA in Colorectal Cancer. Natural Product Communications 16:3, pages 1934578X2110042.
Crossref